About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.10 (+1.94%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
PHAR price activity
Last Price
$12.100
Change (24hr)
0.23 USD (1.94%)
Volume
23.26K
Volume (4w avg)
-
Open
$11.85
Day Range
$11.85 - $12.28
Previous Close
$11.87
Last Trade
28 Oct, 6:05 pm GMT+0
Delayed
28 Oct, 6:05 pm GMT+0
PHAR price performance
Delayed
28 Oct, 6:05 pm GMT+0
PHAR Market Signals